Trial
NCT04129515
NovoTTF-200A + Pembrolizumab In Melanoma Brain Metastasis
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Brown University
Collaborators
NovoCure Ltd.
Condition
Metastatic Melanoma
Intervention
NovoTTF-200A
Why stopped
Contract Issues
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-02